No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Anatara Lifesciences Says Phase Two Trial Unlikely to Achieve Primary Endpoint; Shares Fall 74% to All-Time Low
Anatara Lifesciences Ltd: Appendix 4D & Half Year Report 31 December 2024
Anatara Lifesciences Receives Australian Patent for Gastrointestinal Product; Shares Fall 8%
ASX Small-Cap Stocks to Watch
Anatara Lifesciences Ltd Names New Company Secretary
Anatara Lifesciences Ltd: Annual Report to shareholders